Vision 2020

Rethinking Generics

Our vision is to set a new standard for our industry visible in our 6Ps: How we develop and select our Portfolio, work with strategic Partners, enhance our Productivity and Profit and how we respectfully treat People and our Planet. This is the foundation of our Vision 2020.

With the aim of being a top 10 player, our vision is to become a pharmaceutical company of tomorrow, setting a new standard in generics by combining our collective experiences with an understanding of our customers’ needs.

Market dynamics

The reality facing the generic pharmaceutical industry today is a continuous decline towards a purely commodity-based business, creating tremendous pressures on operating costs. This provides both challenges and opportunities for Alvogen. 

The future of a successful generic pharmaceuticals company rests on creating a lean, flexible, multinational operation that overcomes the challenges of the traditional generic business model. History has taught us that challenging times create real opportunities for change – new ideas and new approaches.

Purpose and Vision

We are rethinking generics, with a radical new business model that creates the pharmaceutical company of tomorrow. Our employees have an inherent thirst for change that is clearly visible in our business model, processes and actions.

Like athletes, inventors and explorers before us, we know that there can always be a better way to do things, if only we dare to challenge the status quo and rethink the future. Alvogen aims to build a top-10 global generics player.

  • We are rethinking generics by creating a radical new business model, that enhances quality of life and delivers exceptional value to all our stakeholders.
  • We are the pharmaceutical company of tomorrow, setting a new standard in generics by combining our collective experiences with an understanding of our customers' needs.
  • Three main pillars support our ambitious growth strategy: Targeted selection of products and markets, delivery of operational effectiveness and strategic selection of people and partners.